Daniel O’Connor
Johns Hopkins University(US)Johns Hopkins Medicine(US)Association of the British Pharmaceutical Industry(GB)University of San Francisco(US)Royal Agricultural University(GB)National Patient Safety Foundation(US)
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Advanced Radiotherapy Techniques, Medical Imaging Techniques and Applications, Radiation Therapy and Dosimetry, Pharmaceutical Economics and Policy
Most-Cited Works
- → Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols(2018)779 cited
- → ASPP Proteins Specifically Stimulate the Apoptotic Function of p53(2001)663 cited
- → iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human(2003)374 cited
- → International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium(2020)299 cited
- → To die or not to die: how does p53 decide?(2004)276 cited
- → RB Regulates the Stability and the Apoptotic Function of p53 via MDM2(1999)255 cited